Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BGB149 |
Synonyms | |
Therapy Description |
BGB149 is an monoclonal antibody that targets AXL (PMID: 32148495). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BGB149 | Tilvestamab|BGB 149|BGB-149 | AXL Antibody 5 | BGB149 is an monoclonal antibody that targets AXL (PMID: 32148495). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04893551 | Phase I | BGB149 | A Study of Tilvestamab (BGB149) in Relapsed, Platinum-resistant, High-grade Serous Ovarian Cancer (HGSOC) Participants | Terminated | NOR | GBR | 2 |